{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:00:17Z","timestamp":1787936417226,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum D\u00fcsseldorf. Anstalt \u00f6ffentlichen Rechts"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Aneurysmal subarachnoid hemorrhage (aSAH) remains a devastating cerebrovascular condition with significant morbidity and mortality. While inflammation plays a critical role in post-hemorrhagic complications, the specific polarization dynamics of monocyte and T cell subpopulations in this context remain poorly understood. This study aims to investigate these immune cell shifts and their correlation with major complications such as angiographic cerebral vasospasm and delayed cerebral ischemia (DCI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective, controlled observational single-center cohort study in a neurovascular university center of maximum care in Germany. A total of 75 patients with aSAH and 20 healthy controls were included. Blood samples were collected on days 1, 4, 7, and 11 post-bleeding. Flow cytometry was used to analyze monocyte (M1, intermediate, M2) and T cell (Th1, Th2, Th17, Treg) polarization patterns. Primary outcomes included the incidence of angiographic cerebral vasospasm, clinical DCI and\/or cerebral infarction due to DCI, and clinical outcome assessed at 6 months via the modified Rankin Scale (mRS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared to healthy controls, patients with aSAH exhibited a significant decrease in anti-inflammatory alternatively activated monocytes (6.3% vs. 3.0%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04) within 24\u00a0h post-bleeding, an increase in pro-inflammatory Th17 T cells (36.3% vs. 6.2%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and decrease in anti-inflammatory Th2 cells (45.5% vs. 75.2%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). A loss of anti-inflammatory alternatively activated monocytes was observed prior to the onset of angiographic cerebral vasospasm (3.8% vs. 2.7%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031) and DCI (4.2% vs. 2.9%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.006). No significant correlation was found between immune cell subpopulations and long-term clinical outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study demonstrates a shift toward pro-inflammatory immune cell subpopulations following aSAH, with significant losses of alternatively activated monocytes preceding major complications such as vasospasm and DCI. These findings suggest that immune subpopulation profiling may hold potential as a diagnostic and therapeutic tool in the context of aSAH-related complications. Future studies should aim to clarify whether the observed peripheral immune changes reflect analogous intracerebral immune mechanisms and whether modulating these pathways can improve clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12974-025-03578-1","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:24:52Z","timestamp":1764401092000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Deep immunophenotyping in aneurysmal subarachnoid hemorrhage: a prospective and controlled clinical study"],"prefix":"10.1186","volume":"23","author":[{"given":"Bj\u00f6rn B.","family":"Hofmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilaware","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"H\u00e4nggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajjad","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"3578_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s1474-4422(09)70126-7","volume":"8","author":"DJ Nieuwkamp","year":"2009","unstructured":"Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 2009;8:635\u201342. https:\/\/doi.org\/10.1016\/s1474-4422(09)70126-7.","journal-title":"Lancet Neurol"},{"key":"3578_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s10143-017-0827-y","volume":"41","author":"JH van Lieshout","year":"2018","unstructured":"van Lieshout JH, Dibue-Adjei M, Cornelius JF, Slotty PJ, Schneider T, Restin T, et al. An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage. Neurosurg Rev. 2018;41:917\u201330. https:\/\/doi.org\/10.1007\/s10143-017-0827-y.","journal-title":"Neurosurg Rev"},{"key":"3578_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-021-01136-9","volume":"21","author":"ML Osgood","year":"2021","unstructured":"Osgood ML. Aneurysmal subarachnoid hemorrhage: review of the pathophysiology and management strategies. Curr Neurol Neurosci Rep. 2021;21:1\u201311.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3578_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13050824","volume":"13","author":"BB Hofmann","year":"2023","unstructured":"Hofmann BB, Fischer I, Donaldson DM, Abusabha Y, Karadag C, Muhammad S, et al. Evaluation of MTT heterogeneity of perfusion CT imaging in the early brain injury phase: an insight into aSAH pathopysiology. Brain Sci. 2023;13:824. https:\/\/doi.org\/10.3390\/brainsci13050824.","journal-title":"Brain Sci"},{"key":"3578_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/s0140-6736(07)60153-6","volume":"369","author":"J van Gijn","year":"2007","unstructured":"van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369:306\u201318. https:\/\/doi.org\/10.1016\/s0140-6736(07)60153-6.","journal-title":"Lancet"},{"key":"3578_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17040497","volume":"17","author":"BP Lucke-Wold","year":"2016","unstructured":"Lucke-Wold BP, Logsdon AF, Manoranjan B, Turner RC, McConnell E, Vates GE, et al. Aneurysmal subarachnoid hemorrhage and neuroinflammation: a comprehensive review. Int J Mol Sci. 2016;17:497.","journal-title":"Int J Mol Sci"},{"key":"3578_CR7","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2174\/1570159X16666180412110919","volume":"16","author":"U Schneider","year":"2018","unstructured":"Schneider U, Xu R, Vajkoczy P. Inflammatory events following subarachnoid hemorrhage (SAH). Curr Neuropharmacol. 2018;16:1385\u201395.","journal-title":"Curr Neuropharmacol"},{"key":"3578_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s13311-019-00829-x","volume":"17","author":"AP Coulibaly","year":"2020","unstructured":"Coulibaly AP, Provencio JJ. Aneurysmal subarachnoid hemorrhage: an overview of inflammation-induced cellular changes. Neurotherapeutics. 2020;17:436\u201345.","journal-title":"Neurotherapeutics"},{"key":"3578_CR9","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1007\/s10143-021-01525-1","volume":"44","author":"J Feghali","year":"2021","unstructured":"Feghali J, Kim J, Gami A, Rapaport S, Caplan JM, McDougall CG, et al. Monocyte-based inflammatory indices predict outcomes following aneurysmal subarachnoid hemorrhage. Neurosurg Rev. 2021;44:3499\u2013507. https:\/\/doi.org\/10.1007\/s10143-021-01525-1.","journal-title":"Neurosurg Rev"},{"key":"3578_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105861","volume":"30","author":"S Yun","year":"2021","unstructured":"Yun S, Yi HJ, Lee DH, Sung JH. Systemic inflammation response index and systemic immune-inflammation index for predicting the prognosis of patients with aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis. 2021;30:105861.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"3578_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2024.08.095","author":"K Li","year":"2024","unstructured":"Li K, Khan D, Fischer I, Muhammad S. Systemic c-reactive protein predicts cerebral vasospasm and delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage: a retrospective observational study. World Neurosurg. 2024. https:\/\/doi.org\/10.1016\/j.wneu.2024.08.095.","journal-title":"World Neurosurg"},{"key":"3578_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67322-0","volume":"14","author":"I Fischer","year":"2024","unstructured":"Fischer I, Lala R, Donaldson DM, Schieferdecker S, Hofmann BB, Cornelius JF, et al. Prognostic value of platelet levels in patients with aneurysmal subarachnoid hemorrhage. Sci Rep. 2024;14:16743. https:\/\/doi.org\/10.1038\/s41598-024-67322-0.","journal-title":"Sci Rep"},{"key":"3578_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13040940","author":"K Li","year":"2024","unstructured":"Li K, Khan D, Fischer I, H\u00e4nggi D, Cornelius JF, Muhammad S. CLR (C-reactive protein to lymphocyte ratio) served as a promising predictive biomarker for cerebral vasospasm in aneurysmal subarachnoid hemorrhage (aSAH): a retrospective cohort study. J Clin Med. 2024. https:\/\/doi.org\/10.3390\/jcm13040940.","journal-title":"J Clin Med"},{"key":"3578_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147355","author":"S Muhammad","year":"2021","unstructured":"Muhammad S, H\u00e4nggi D. Inflammation and anti-inflammatory targets after aneurysmal subarachnoid hemorrhage. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22147355.","journal-title":"Int J Mol Sci"},{"key":"3578_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1182\/blood.V95.1.231","volume":"95","author":"M Vukmanovic-Stejic","year":"2000","unstructured":"Vukmanovic-Stejic M, Vyas B, Gorak-Stolinska P, Noble A, Kemeny DM. Human Tc1 and Tc2\/Tc0 CD8 T-cell clones display distinct cell surface and functional phenotypes. Blood. 2000;95:231\u201340.","journal-title":"Blood"},{"key":"3578_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/968549","author":"N Qu","year":"2013","unstructured":"Qu N, Xu M, Mizoguchi I, Furusawa J-i, Kaneko K, Watanabe K, et al. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol. 2013. https:\/\/doi.org\/10.1155\/2013\/968549.","journal-title":"Clin Dev Immunol"},{"key":"3578_CR17","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.cell.2016.07.006","volume":"166","author":"J van der Veeken","year":"2016","unstructured":"van der Veeken J, Gonzalez AJ, Cho H, Arvey A, Hemmers S, Leslie CS, et al. Memory of inflammation in regulatory T cells. Cell. 2016;166:977\u201390.","journal-title":"Cell"},{"key":"3578_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-023-01683-8","author":"BB Hofmann","year":"2023","unstructured":"Hofmann BB, Donaldson DM, Fischer I, Karadag C, Neyazi M, Piedade GS, et al. Blood pressure affects the early CT perfusion imaging in patients with aSAH reflecting early disturbed autoregulation. Neurocrit Care. 2023. https:\/\/doi.org\/10.1007\/s12028-023-01683-8.","journal-title":"Neurocrit Care"},{"key":"3578_CR19","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7169","author":"BB Hofmann","year":"2021","unstructured":"Hofmann BB, Fischer I, Engel A, Jannusch K, Donaldson DM, Karadag C, et al. MTT heterogeneity in perfusion CT imaging as a predictor of outcome after aneurysmal SAH. AJNR Am J Neuroradiol. 2021. https:\/\/doi.org\/10.3174\/ajnr.A7169.","journal-title":"AJNR Am J Neuroradiol"},{"key":"3578_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11102624","author":"BB Hofmann","year":"2023","unstructured":"Hofmann BB, Karadag C, Rubbert C, Schieferdecker S, Neyazi M, Abusabha Y, et al. Novel insights into pathophysiology of delayed cerebral ischemia: effects of current rescue therapy on microvascular perfusion heterogeneity. Biomedicines. 2023. https:\/\/doi.org\/10.3390\/biomedicines11102624.","journal-title":"Biomedicines"},{"key":"3578_CR21","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000002715","author":"BB Hofmann","year":"2023","unstructured":"Hofmann BB, Fischer I, Neyazi M, Karadag C, Donaldson DM, Abusabha Y, et al. Revisiting the WFNS score: native computed tomography imaging improves identification of patients with false poor grade aneurysmal subarachnoid hemorrhage. Neurosurgery. 2023. https:\/\/doi.org\/10.1227\/neu.0000000000002715.","journal-title":"Neurosurgery"},{"key":"3578_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-023-01879-y","author":"BB Hofmann","year":"2023","unstructured":"Hofmann BB, Donaldson DM, Neyazi M, Abusabha Y, Beseoglu K, H\u00e4nggi D, et al. Clinical outcome prediction of early brain injury in aneurysmal subarachnoid hemorrhage: the SHELTER score. Neurocrit Care. 2023. https:\/\/doi.org\/10.1007\/s12028-023-01879-y.","journal-title":"Neurocrit Care"},{"key":"3578_CR23","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/strokeaha.110.589275","volume":"41","author":"MD Vergouwen","year":"2010","unstructured":"Vergouwen MD, Vermeulen M, van Gijn J, Rinkel GJ, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, Terbrugge KG, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391\u20135. https:\/\/doi.org\/10.1161\/strokeaha.110.589275.","journal-title":"Stroke"},{"key":"3578_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02035","author":"TS Kapellos","year":"2019","unstructured":"Kapellos TS, Bonaguro L, Gem\u00fcnd I, Reusch N, Saglam A, Hinkley ER, et al. Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.02035.","journal-title":"Front Immunol"},{"key":"3578_CR25","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1007\/s12975-019-00764-1","volume":"11","author":"M Mohme","year":"2020","unstructured":"Mohme M, Sauvigny T, Mader MM-D, Schweingruber N, Maire CL, R\u00fcnger A, et al. Immune characterization in aneurysmal subarachnoid hemorrhage reveals distinct monocytic activation and chemokine patterns. Transl Stroke Res. 2020;11:1348\u201361.","journal-title":"Transl Stroke Res"},{"key":"3578_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113535","volume":"336","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Fang Y, Lenahan C, Chen S. The role of immune inflammation in aneurysmal subarachnoid hemorrhage. Exp Neurol. 2021;336:113535.","journal-title":"Exp Neurol"},{"key":"3578_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1027756","volume":"13","author":"J Jin","year":"2022","unstructured":"Jin J, Duan J, Du L, Xing W, Peng X, Zhao Q. Inflammation and immune cell abnormalities in intracranial aneurysm subarachnoid hemorrhage (SAH): relevant signaling pathways and therapeutic strategies. Front Immunol. 2022;13:1027756.","journal-title":"Front Immunol"},{"key":"3578_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12883","volume":"92","author":"A O\u017ca\u0144ska","year":"2020","unstructured":"O\u017ca\u0144ska A, Szymczak D, Rybka J. Pattern of human monocyte subpopulations in health and disease. Scand J Immunol. 2020;92:e12883.","journal-title":"Scand J Immunol"},{"issue":"2","key":"3578_CR29","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1189\/jlb.0307191","volume":"82","author":"D Strauss-Ayali","year":"2007","unstructured":"Strauss-Ayali D, Conrad SM, Mosser DM. Monocyte subpopulations and their differentiation patterns during infection. J Leukoc Biol. 2007;82(2):244\u201352.","journal-title":"J Leukoc Biol"},{"key":"3578_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/intimm\/dxw006","volume":"28","author":"K Hirahara","year":"2016","unstructured":"Hirahara K, Nakayama T. CD4\u2009+\u2009t-cell subsets in inflammatory diseases: beyond the T h 1\/T h 2 paradigm. Int Immunol. 2016;28:163\u201371. https:\/\/doi.org\/10.1093\/intimm\/dxw006.","journal-title":"Int Immunol"},{"key":"3578_CR31","first-page":"235","volume-title":"Clinical immunology (Fifth Edition)","author":"TN Eagar","year":"2019","unstructured":"Eagar TN, Miller SD. 16 - Helper T-Cell subsets and control of the inflammatory response. In: Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand CM, editors. Clinical immunology (Fifth Edition). London: Elsevier; 2019. pp. 235\u2013e245231."},{"issue":"1","key":"3578_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92873-x","volume":"11","author":"SR Chaudhry","year":"2021","unstructured":"Chaudhry SR, Kahlert UD, Kinfe TM, Endl E, Dolf A, Niemel\u00e4 M, et al. Differential polarization and activation dynamics of systemic T helper cell subsets after aneurysmal subarachnoid hemorrhage (SAH) and during post-SAH complications. Sci Rep. 2021;11(1):14226. https:\/\/doi.org\/10.1038\/s41598-021-92873-x.","journal-title":"Sci Rep"},{"key":"3578_CR33","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007;13:1173\u20135. https:\/\/doi.org\/10.1038\/nm1651.","journal-title":"Nat Med"},{"key":"3578_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108856","volume":"24","author":"M Romoli","year":"2023","unstructured":"Romoli M, Giammello F, Mosconi MG, De Mase A, De Marco G, Digiovanni A, et al. Immunological profile of vasospasm after subarachnoid hemorrhage. Int J Mol Sci. 2023;24:8856.","journal-title":"Int J Mol Sci"},{"key":"3578_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1227\/01.neu.0000068863.37133.9e","volume":"53","author":"AS Dumont","year":"2003","unstructured":"Dumont AS, Dumont RJ, Chow MM, Lin CL, Calisaneller T, Ley KF, Kassell NF, Lee KS. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery. 2003;53:123\u201333. https:\/\/doi.org\/10.1227\/01.neu.0000068863.37133.9e. discussion 133\u2009\u2013\u2009125.","journal-title":"Neurosurgery"},{"key":"3578_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.surneu.2009.05.027","volume":"73","author":"KL Chaichana","year":"2010","unstructured":"Chaichana KL, Pradilla G, Huang J, Tamargo RJ. Role of inflammation (leukocyte-endothelial cell interactions) in vasospasm after subarachnoid hemorrhage. World Neurosurg. 2010;73:22\u201341. https:\/\/doi.org\/10.1016\/j.surneu.2009.05.027.","journal-title":"World Neurosurg"},{"key":"3578_CR37","doi-asserted-by":"publisher","unstructured":"Bacigaluppi S, Ivaldi F, Bragazzi NL, Benvenuto F, Gallo F, D\u2019Andrea A, Severi P, Uccelli A, Zona G. An early increase of blood leukocyte subsets in aneurysmal subarachnoid hemorrhage is predictive of vasospasm. Front Neurol. 2020;11. https:\/\/doi.org\/10.3389\/fneur.2020.587039.","DOI":"10.3389\/fneur.2020.587039"},{"key":"3578_CR38","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1161\/STR.0000000000000436","volume":"54","author":"BL Hoh","year":"2023","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, Chou SH-Y, Cruz-Flores S, Dangayach NS, Derdeyn CP, Du R, H\u00e4nggi D, Hetts SW, et al. 2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: A guideline from the American heart association\/American stroke association. Stroke. 2023;54:e314\u201370. https:\/\/doi.org\/10.1161\/STR.0000000000000436.","journal-title":"Stroke"},{"key":"3578_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.630381","author":"S Muhammad","year":"2021","unstructured":"Muhammad S, Chaudhry SR, Dobreva G, Lawton MT, Niemel\u00e4 M, H\u00e4nggi D. Vascular macrophages as therapeutic targets to treat intracranial aneurysms. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.630381.","journal-title":"Front Immunol"},{"key":"3578_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111048","volume":"133","author":"M Han","year":"2021","unstructured":"Han M, Cao Y, Guo X, Chu X, Li T, Xue H, et al. Mesenchymal stem cell-derived extracellular vesicles promote microglial M2 polarization after subarachnoid hemorrhage in rats and involve the AMPK\/NF-\u03baB signaling pathway. Biomed Pharmacother. 2021;133:111048.","journal-title":"Biomed Pharmacother"},{"key":"3578_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.578003","author":"J Park","year":"2020","unstructured":"Park J, Chang JY, Kim JY, Lee JE. Monocyte transmodulation: the next novel therapeutic approach in overcoming ischemic stroke? Front Neurol. 2020. https:\/\/doi.org\/10.3389\/fneur.2020.578003.","journal-title":"Front Neurol"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03578-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03578-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03578-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T12:00:47Z","timestamp":1769515247000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-025-03578-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3578"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03578-1","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"30 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki declaration and its later amendments. The study was approved by the ethics committee of the Medical Faculty of Heinrich-Heine-University, Germany (study ID: 2020\u2009\u2212\u20091037_1). Written consent was needed for the participation in this study. The written consent of patients capable of giving informed consent was obtained immediately. Incapacitated patients were initially enrolled in accordance with the ethics approval, and consent was obtained from the patient themselves or their authorized representative at the earliest possible time.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}